Texas Subject | MEDICINE & PRESCRIPTION DRUGS

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
TXHB1584EnrollRelating to health benefit plan coverage of prescription drugs for stage-four advanced, metastatic cancer.
[Detail][Text][Discuss]
2019-06-15
Effective on 9/1/19
TXSB683PassRelating to the licensing and regulation of pharmacists and pharmacies.
[Detail][Text][Discuss]
2019-06-14
Effective on 9/1/19
TXHB1849PassRelating to the possession and administration of epinephrine auto-injectors in day-care centers; limiting liability.
[Detail][Text][Discuss]
2019-06-14
Effective immediately
TXHB2174PassRelating to controlled substance prescriptions and reimbursement for treatment for certain substance use disorders; authorizing a fee.
[Detail][Text][Discuss]
2019-06-14
Effective on 9/1/19
TXSB1056PassRelating to the authority of physicians to delegate to certain pharmacists the implementation and modification of a patient's drug therapy.
[Detail][Text][Discuss]
2019-06-14
Effective on 9/1/19
TXHB2536PassRelating to transparency related to drug costs.
[Detail][Text][Discuss]
2019-06-14
Effective on 9/1/19
TXSB1283PassRelating to the availability under Medicaid of certain drugs used to treat human immunodeficiency virus or prevent acquired immune deficiency syndrome.
[Detail][Text][Discuss]
2019-06-14
Effective on 9/1/19
TXHB2050PassRelating to consent requirements for the prescription of certain psychoactive medications to residents of nursing facilities and related institutions.
[Detail][Text][Discuss]
2019-06-14
Effective on 9/1/19
TXHB3284PassRelating to the prescribing and dispensing of controlled substances under the Texas Controlled Substances Act; authorizing a fee; providing for administrative penalties; creating criminal offenses.
[Detail][Text][Discuss]
2019-06-14
Effective on 9/1/19
TXHB3285PassRelating to programs and initiatives to prevent and respond to opioid addiction, misuse, abuse, and overdose and identify and treat co-occurring substance use disorders and mental illness.
[Detail][Text][Discuss]
2019-06-14
Effective on 9/1/19
TXHB3703PassRelating to the prescription of low-THC cannabis for medical use by certain qualified physicians to patients with certain medical conditions.
[Detail][Text][Discuss]
2019-06-14
Effective immediately
TXHB4260PassRelating to the possession and administration of an epinephrine auto-injector by certain entities.
[Detail][Text][Discuss]
2019-06-14
Effective on 9/1/19
TXHB2088PassRelating to providing information and other resources regarding safe disposal of Schedule II controlled substance prescription drugs.
[Detail][Text][Discuss]
2019-06-10
Effective on 9/1/19
TXHB2454PassRelating to continuing education requirements for certain health professionals regarding pain management and the prescribing of opioids.
[Detail][Text][Discuss]
2019-06-10
Effective on 9/1/19
TXHB2594PassRelating to disposal of controlled substance prescription drugs by hospice service providers.
[Detail][Text][Discuss]
2019-06-10
Effective on 9/1/19
TXSB1207PassRelating to the operation and administration of Medicaid, including the Medicaid managed care program and the medically dependent children (MDCP) waiver program.
[Detail][Text][Discuss]
2019-06-10
Effective on 9/1/19
TXSB1564PassRelating to access to certain medication-assisted treatment.
[Detail][Text][Discuss]
2019-06-10
Effective immediately
TXSB1096PassRelating to the Medicaid managed care program, including the provision of pharmacy benefits.
[Detail][Text][Discuss]
2019-06-10
Effective on 9/1/19
TXSB1827PassRelating to the possession and emergency administration of an epinephrine auto-injector by law enforcement agencies and peace officers.
[Detail][Text][Discuss]
2019-06-10
Effective on 9/1/19
TXSB437PassRelating to prohibited practices by a life insurance company relating to an individual's prescription for or obtainment of an opioid antagonist.
[Detail][Text][Discuss]
2019-06-07
Effective on 9/1/19
TXHB1455PassRelating to the audit of wholesale invoices during certain audits of pharmacists and pharmacies.
[Detail][Text][Discuss]
2019-06-07
Effective on 9/1/19
TXSB1947PassRelating to the regulation of the prescribing and dispensing of controlled substances by veterinarians.
[Detail][Text][Discuss]
2019-06-04
Effective on 9/1/19
TXSB1780PassRelating to value-based arrangements in the Medicaid vendor drug program.
[Detail][Text][Discuss]
2019-05-28
Effective on 9/1/19
TXHB3388EngrossRelating to the reimbursement of prescription drugs under Medicaid and the child health plan program.
[Detail][Text][Discuss]
2019-05-25
Conf. Comm. Report distributed
TXHB2243PassRelating to the use of prescription asthma medicine on public and private school campuses.
[Detail][Text][Discuss]
2019-05-24
Effective immediately
TXHB2425PassRelating to the authority of physicians to delegate to certain pharmacists the implementation and modification of a patient's drug therapy.
[Detail][Text][Discuss]
2019-05-24
Effective on 9/1/19
TXHB2817EngrossRelating to the contractual relationship between a pharmacist or pharmacy and a health benefit plan issuer or pharmacy benefit manager.
[Detail][Text][Discuss]
2019-05-22
Placed on intent calendar
TXSB420EngrossRelating to dispenser requirements for refilling prescriptions for certain controlled substances.
[Detail][Text][Discuss]
2019-05-17
Committee report sent to Calendars
TXHB1518PassRelating to the regulation of the sale of dextromethorphan to minors; providing civil penalties.
[Detail][Text][Discuss]
2019-05-17
Effective on 9/1/19
TXHB476PassRelating to certain duties of public institutions of higher education and the Department of State Health Services regarding policies on the use of epinephrine auto-injectors by public institutions of higher education.
[Detail][Text][Discuss]
2019-05-16
Effective on 9/1/19
TXSB2438IntroRelating to the authority of certain advanced practice registered nurses.
[Detail][Text][Discuss]
2019-05-16
To Senate Business & Commerce Committee
TXHB2099EngrossRelating to modification of certain prescription drug benefits and coverage offered by certain health benefit plans.
[Detail][Text][Discuss]
2019-05-15
Co-sponsor authorized
TXHB2811EngrossRelating to the prescribing of controlled substances and dangerous drugs for acute pain.
[Detail][Text][Discuss]
2019-05-15
To Senate Health & Human Services Committee
TXSB2316EngrossRelating to controlled substance prescriptions under the Texas Controlled Substances Act; creating a criminal offense.
[Detail][Text][Discuss]
2019-05-14
Committee report sent to Calendars
TXHB2250EngrossRelating to the prescribing and ordering of Schedule II controlled substances by certain advanced practice registered nurses and physician assistants.
[Detail][Text][Discuss]
2019-05-13
To Senate Health & Human Services Committee
TXHB2576EngrossRelating to prescribing and dispensing certain controlled substances to patients diagnosed with sickle cell disease.
[Detail][Text][Discuss]
2019-05-10
To Senate Health & Human Services Committee
TXHB937IntroRelating to health benefit plan coverage of prescription contraceptive drugs.
[Detail][Text][Discuss]
2019-05-09
Placed on General State Calendar
TXHB1264PassRelating to pharmacist communications to prescribing practitioners regarding certain dispensed biological products.
[Detail][Text][Discuss]
2019-05-07
Effective immediately
TXHB2766EngrossRelating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.
[Detail][Text][Discuss]
2019-05-07
To Senate Health & Human Services Committee
TXHB562IntroRelating to warning labels for opioid prescription drugs.
[Detail][Text][Discuss]
2019-05-01
Committee report sent to Calendars
TXSB363EngrossRelating to access to certain controlled substance prescription information.
[Detail][Text][Discuss]
2019-05-01
To House Homeland Security & Public Safety Committee
TXHB3685IntroRelating to pharmacy benefits provided through the Medicaid managed care program.
[Detail][Text][Discuss]
2019-05-01
Committee report sent to Calendars
TXHB4145IntroRelating to the prescription of a controlled substance to certain patients for the treatment of pain.
[Detail][Text][Discuss]
2019-05-01
Left pending in committee
TXHB4285IntroRelating to the authority of pharmacists to furnish certain medications.
[Detail][Text][Discuss]
2019-05-01
To House Public Health Committee
TXHB805IntroRelating to access to certain investigational drugs, biological products, and devices that are in clinical trials by patients with severe chronic diseases.
[Detail][Text][Discuss]
2019-04-30
Committee report sent to Calendars
TXHB4297IntroRelating to the authority of physicians to delegate to certain pharmacists the implementation and modification of a patient's drug therapy.
[Detail][Text][Discuss]
2019-04-30
Committee report sent to Calendars
TXHB698IntroRelating to certain protected practices of pharmacists and pharmacies regarding amounts charged for prescription drugs.
[Detail][Text][Discuss]
2019-04-29
Committee report sent to Calendars
TXHB800EngrossRelating to covered benefits under the child health plan.
[Detail][Text][Discuss]
2019-04-29
To Senate Health & Human Services Committee
TXHB3881EngrossRelating to the use of epinephrine auto-injectors in primary and secondary schools.
[Detail][Text][Discuss]
2019-04-29
To Senate Education Committee
TXHB1706IntroRelating to the provision of pharmacy services through a telepharmacy system.
[Detail][Text][Discuss]
2019-04-24
Committee report sent to Calendars
Syndicate content
feedback